Symbol:
Pla2g4f
Name:
phospholipase A2, group IVF
RGD ID:
1593370
Description:
Predicted to enable calcium ion binding activity; calcium-dependent phospholipid binding activity; and phospholipase activity. Predicted to be involved in glycerophospholipid catabolic process. Predicted to act upstream of or within arachidonate secretion; cellular response to antibiotic; and prostaglandin biosynthetic process. Predicted to be located in cytoplasm. Predicted to be active in cytosol; ruffle membrane; and vesicle. Orthologous to human PLA2G4F (phospholipase A2 group IVF); PARTICIPATES IN alpha-linolenic acid metabolic pathway; arachidonic acid metabolic pathway; ether lipid metabolic pathway; INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 2,3,7,8-Tetrachlorodibenzofuran; bisphenol A.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
cytosolic phospholipase A2 zeta; LOC691907; similar to cytosolic phospholipase A2 zeta
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
PLA2G4F (phospholipase A2 group IVF)
HGNC
Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, Panther
Mus musculus (house mouse):
Pla2g4f (phospholipase A2, group IVF)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Pla2g4f (phospholipase A2 group IVF)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
PLA2G4F (phospholipase A2 group IVF)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
PLA2G4F (phospholipase A2 group IVF)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Pla2g4f (phospholipase A2 group IVF)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
PLA2G4F (phospholipase A2 group IVF)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
PLA2G4F (phospholipase A2 group IVF)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Pla2g4f (phospholipase A2 group IVF)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Other homologs 2
Homo sapiens (human):
SS18 (SS18 subunit of BAF chromatin remodeling complex)
HGNC
OMA
Alliance orthologs 3
Homo sapiens (human):
PLA2G4F (phospholipase A2 group IVF)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Mus musculus (house mouse):
Pla2g4f (phospholipase A2, group IVF)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
pla2g4f.1 (phospholipase A2, group IVF, tandem duplicate 1)
Alliance
DIOPT (Hieranoid|OMA|OrthoFinder|PANTHER)
Danio rerio (zebrafish):
pla2g4f.2 (phospholipase A2, group IVF, tandem duplicate 2)
Alliance
DIOPT (Hieranoid|OMA|OrthoFinder|PANTHER)
Xenopus tropicalis (tropical clawed frog):
pla2g4f
Alliance
DIOPT (Hieranoid|InParanoid|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 3 127,702,603 - 127,720,429 (-) NCBI GRCr8 mRatBN7.2 3 107,249,053 - 107,266,201 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 3 107,250,075 - 107,264,689 (-) Ensembl mRatBN7.2 Ensembl Rnor_6.0 3 112,068,617 - 112,083,978 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 3 112,072,330 - 112,084,144 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 3 118,616,780 - 118,631,305 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 3 106,786,813 - 106,800,543 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 Celera 3 106,157,546 - 106,174,304 (-) NCBI Celera Cytogenetic Map 3 q35 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Pla2g4f Rat 1,2-dimethylhydrazine increases expression ISO Pla2g4f (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of PLA2G4F mRNA CTD PMID:22206623 Pla2g4f Rat 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO Pla2g4f (Mus musculus) 6480464 2 more ... CTD PMID:31388691 Pla2g4f Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of PLA2G4F mRNA CTD PMID:33387578 Pla2g4f Rat 2,3,7,8-Tetrachlorodibenzofuran increases expression EXP 6480464 2 more ... CTD PMID:32109520 Pla2g4f Rat 2-hydroxypropanoic acid increases expression ISO PLA2G4F (Homo sapiens) 6480464 Lactic Acid results in increased expression of PLA2G4F mRNA CTD PMID:30851411 Pla2g4f Rat 3,4-methylenedioxymethamphetamine decreases expression ISO Pla2g4f (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of PLA2G4F mRNA CTD PMID:20188158 Pla2g4f Rat aflatoxin B1 increases methylation ISO PLA2G4F (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of PLA2G4F gene CTD PMID:27153756 Pla2g4f Rat aristolochic acid A increases expression ISO PLA2G4F (Homo sapiens) 6480464 aristolochic acid I results in increased expression of PLA2G4F mRNA CTD PMID:33212167 Pla2g4f Rat arsane multiple interactions ISO PLA2G4F (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of PLA2G4F mRNA CTD PMID:32525701 Pla2g4f Rat arsenic atom multiple interactions ISO PLA2G4F (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of PLA2G4F mRNA CTD PMID:32525701 Pla2g4f Rat Azoxymethane multiple interactions ISO Pla2g4f (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PLA2G4F mRNA CTD PMID:29950665 Pla2g4f Rat benzene increases expression ISO Pla2g4f (Mus musculus) 6480464 Benzene results in increased expression of PLA2G4F mRNA CTD PMID:34624356 Pla2g4f Rat beta-damascenone increases expression ISO Pla2g4f (Mus musculus) 6480464 beta-damascenone results in increased expression of PLA2G4F mRNA CTD PMID:22982537 Pla2g4f Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PLA2G4F mRNA CTD PMID:25181051 Pla2g4f Rat dextran sulfate multiple interactions ISO Pla2g4f (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PLA2G4F mRNA CTD PMID:29950665 Pla2g4f Rat dimethylarsinic acid multiple interactions ISO Pla2g4f (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PLA2G4F mRNA CTD PMID:34876320 Pla2g4f Rat endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of PLA2G4F mRNA CTD PMID:29391264 Pla2g4f Rat ethylparaben increases expression ISO PLA2G4F (Homo sapiens) 6480464 ethyl-p-hydroxybenzoate results in increased expression of PLA2G4F mRNA CTD PMID:37690743 Pla2g4f Rat fulvestrant increases methylation ISO PLA2G4F (Homo sapiens) 6480464 Fulvestrant results in increased methylation of PLA2G4F gene CTD PMID:31601247 Pla2g4f Rat genistein decreases expression ISO Pla2g4f (Mus musculus) 6480464 Genistein results in decreased expression of PLA2G4F mRNA CTD PMID:32186404 Pla2g4f Rat leflunomide increases expression ISO PLA2G4F (Homo sapiens) 6480464 leflunomide results in increased expression of PLA2G4F mRNA CTD PMID:28988120 Pla2g4f Rat methylarsonic acid multiple interactions ISO Pla2g4f (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PLA2G4F mRNA CTD PMID:34876320 Pla2g4f Rat ozone multiple interactions ISO Pla2g4f (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of PLA2G4F mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of PLA2G4F mRNA CTD PMID:34911549 Pla2g4f Rat paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of PLA2G4F mRNA CTD PMID:33387578 Pla2g4f Rat paraquat increases expression ISO Pla2g4f (Mus musculus) 6480464 Paraquat results in increased expression of PLA2G4F mRNA CTD PMID:28012437 Pla2g4f Rat pirinixic acid increases expression ISO Pla2g4f (Mus musculus) 6480464 pirinixic acid results in increased expression of PLA2G4F mRNA CTD PMID:20813756 Pla2g4f Rat rac-lactic acid increases expression ISO PLA2G4F (Homo sapiens) 6480464 Lactic Acid results in increased expression of PLA2G4F mRNA CTD PMID:30851411 Pla2g4f Rat sodium arsenate multiple interactions ISO PLA2G4F (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of PLA2G4F mRNA CTD PMID:32525701 Pla2g4f Rat sodium arsenate multiple interactions ISO Pla2g4f (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PLA2G4F mRNA CTD PMID:34876320 Pla2g4f Rat sodium arsenite affects expression ISO PLA2G4F (Homo sapiens) 6480464 sodium arsenite affects the expression of PLA2G4F mRNA CTD PMID:34032870 Pla2g4f Rat sodium arsenite multiple interactions ISO Pla2g4f (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PLA2G4F mRNA CTD PMID:34876320 Pla2g4f Rat thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of PLA2G4F mRNA CTD PMID:23411599 and PMID:34492290 Pla2g4f Rat titanium dioxide multiple interactions ISO Pla2g4f (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PLA2G4F mRNA CTD PMID:29950665 Pla2g4f Rat triclosan decreases expression ISO PLA2G4F (Homo sapiens) 6480464 Triclosan results in decreased expression of PLA2G4F mRNA CTD PMID:30510588 Pla2g4f Rat triptonide increases expression ISO Pla2g4f (Mus musculus) 6480464 triptonide results in increased expression of PLA2G4F mRNA CTD PMID:33045310 Pla2g4f Rat urethane decreases expression ISO PLA2G4F (Homo sapiens) 6480464 Urethane results in decreased expression of PLA2G4F mRNA CTD PMID:28818685 Pla2g4f Rat valproic acid increases methylation ISO PLA2G4F (Homo sapiens) 6480464 Valproic Acid results in increased methylation of PLA2G4F gene CTD PMID:29154799 Pla2g4f Rat zoledronic acid decreases expression ISO PLA2G4F (Homo sapiens) 6480464 zoledronic acid results in decreased expression of PLA2G4F mRNA CTD PMID:24714768
Imported Annotations - KEGG (archival)
1,2-dimethylhydrazine (ISO) 2,3',4,4',5-Pentachlorobiphenyl (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP) 2,3,7,8-Tetrachlorodibenzofuran (EXP) 2-hydroxypropanoic acid (ISO) 3,4-methylenedioxymethamphetamine (ISO) aflatoxin B1 (ISO) aristolochic acid A (ISO) arsane (ISO) arsenic atom (ISO) Azoxymethane (ISO) benzene (ISO) beta-damascenone (ISO) bisphenol A (EXP) dextran sulfate (ISO) dimethylarsinic acid (ISO) endosulfan (EXP) ethylparaben (ISO) fulvestrant (ISO) genistein (ISO) leflunomide (ISO) methylarsonic acid (ISO) ozone (ISO) paracetamol (EXP) paraquat (ISO) pirinixic acid (ISO) rac-lactic acid (ISO) sodium arsenate (ISO) sodium arsenite (ISO) thioacetamide (EXP) titanium dioxide (ISO) triclosan (ISO) triptonide (ISO) urethane (ISO) valproic acid (ISO) zoledronic acid (ISO)
Pla2g4f (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 3 127,702,603 - 127,720,429 (-) NCBI GRCr8 mRatBN7.2 3 107,249,053 - 107,266,201 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 3 107,250,075 - 107,264,689 (-) Ensembl mRatBN7.2 Ensembl Rnor_6.0 3 112,068,617 - 112,083,978 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 3 112,072,330 - 112,084,144 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 3 118,616,780 - 118,631,305 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 3 106,786,813 - 106,800,543 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 Celera 3 106,157,546 - 106,174,304 (-) NCBI Celera Cytogenetic Map 3 q35 NCBI
PLA2G4F (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 15 42,139,034 - 42,156,636 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 15 42,139,034 - 42,156,636 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 15 42,431,232 - 42,448,834 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 15 40,220,688 - 40,236,102 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Celera 15 19,201,035 - 19,216,542 (-) NCBI Celera Cytogenetic Map 15 q15.1 NCBI HuRef 15 19,281,808 - 19,297,315 (-) NCBI HuRef CHM1_1 15 42,551,786 - 42,567,298 (-) NCBI CHM1_1 T2T-CHM13v2.0 15 39,945,057 - 39,962,659 (-) NCBI T2T-CHM13v2.0
Pla2g4f (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 2 120,130,433 - 120,144,646 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 2 120,130,438 - 120,144,646 (-) Ensembl GRCm39 Ensembl GRCm38 2 120,299,952 - 120,314,165 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 2 120,299,957 - 120,314,165 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 2 120,125,693 - 120,139,901 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 2 119,991,407 - 120,005,606 (-) NCBI MGSCv36 mm8 Celera 2 121,454,326 - 121,468,544 (-) NCBI Celera Cytogenetic Map 2 E5 NCBI cM Map 2 60.31 NCBI
Pla2g4f (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955416 8,873,356 - 8,889,940 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955416 8,876,560 - 8,889,764 (-) NCBI ChiLan1.0 ChiLan1.0
PLA2G4F (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 16 31,382,843 - 31,400,507 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 15 35,536,001 - 35,553,667 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 15 21,095,474 - 21,110,983 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 15 39,253,819 - 39,271,482 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 15 39,253,819 - 39,271,482 (-) Ensembl panpan1.1 panPan2
PLA2G4F (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 30 9,150,325 - 9,165,610 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 30 9,150,971 - 9,164,608 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 30 9,205,449 - 9,223,103 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 30 9,281,972 - 9,299,572 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 30 9,285,977 - 9,299,492 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 30 9,202,339 - 9,219,941 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 30 9,307,320 - 9,324,957 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 30 9,441,666 - 9,459,261 (-) NCBI UU_Cfam_GSD_1.0
Pla2g4f (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024408640 87,591,311 - 87,607,176 (-) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936471 5,439,866 - 5,454,331 (-) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936471 5,439,389 - 5,454,437 (-) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
PLA2G4F (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 1 129,201,069 - 129,217,008 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 1 129,200,568 - 129,218,417 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 1 144,142,382 - 144,149,527 (+) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
PLA2G4F (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 26 40,835,777 - 40,852,021 (+) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 26 40,836,266 - 40,852,054 (+) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666048 100,149,142 - 100,167,303 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Pla2g4f (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 127 Count of miRNA genes: 96 Interacting mature miRNAs: 104 Transcripts: ENSRNOT00000010959 Prediction methods: Microtar, Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
2312673 Scl63 Serum cholesterol level QTL 63 0.001 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 3 98535255 168026850 Rat 2301414 Kidm37 Kidney mass QTL 37 0.001 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 3 70653097 121056321 Rat 1582238 Bw68 Body weight QTL 68 3.2 0.0064 body mass (VT:0001259) body weight (CMO:0000012) 3 53184593 115665732 Rat 2302373 Gluco39 Glucose level QTL 39 5.01 blood glucose amount (VT:0000188) blood glucose level area under curve (AUC) (CMO:0000350) 3 98535386 161695835 Rat 1582239 Epfw1 Epididymal fat weight QTL 1 4.5 0.0006 epididymal fat pad mass (VT:0010421) epididymal fat pad weight to body weight ratio (CMO:0000658) 3 53184593 115665732 Rat 70216 Cm14 Cardiac mass QTL 14 2.1 heart mass (VT:0007028) heart wet weight (CMO:0000069) 3 31172320 163586636 Rat 2292591 Esta4 Estrogen-induced thymic atrophy QTL 4 thymus mass (VT:0004954) thymus wet weight (CMO:0000855) 3 47233211 147415807 Rat 1358362 Srcrt2 Stress Responsive Cort QTL 2 2.78 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 3 38192233 133483320 Rat 1582216 Bw65 Body weight QTL 65 6.3 body mass (VT:0001259) body weight (CMO:0000012) 3 102200529 115665732 Rat 737818 Hcar12 Hepatocarcinoma resistance QTL 12 2.6 liver integrity trait (VT:0010547) volume of individual liver tumorous lesion (CMO:0001078) 3 29463235 118376539 Rat 1582218 Bw74 Body weight QTL 74 3.9 0.0021 body mass (VT:0001259) body weight (CMO:0000012) 3 53184593 115665732 Rat 1582219 Bw63 Body weight QTL 63 3.8 0.001 body mass (VT:0001259) body weight (CMO:0000012) 3 96127817 115665732 Rat 1582221 Kidm30 Kidney mass QTL 30 3.5 0.0008 kidney mass (VT:0002707) both kidneys wet weight (CMO:0000085) 3 64655305 115665732 Rat 1581568 Rf53 Renal function QTL 53 urine total protein amount (VT:0000032) urine protein excretion rate to body weight ratio (CMO:0001099) 3 56395968 161299569 Rat 1582210 Bw71 Body weight QTL 71 3.3 0.0012 body mass (VT:0001259) body weight (CMO:0000012) 3 64655305 115665732 Rat 7387306 Bw124 Body weight QTL 124 3.2 0.0003 body mass (VT:0001259) body weight (CMO:0000012) 3 84091273 129091273 Rat 1300111 Rf12 Renal function QTL 12 3.78 renal blood flow trait (VT:2000006) absolute change in renal blood flow rate (CMO:0001168) 3 61017749 121056321 Rat 724523 Tsu1 Thymus enlargement suppressive QTL 1 3.84 thymus mass (VT:0004954) thymus weight to body weight ratio (CMO:0000612) 3 50437504 115638231 Rat 1600376 Arunc5 Aerobic running capacity QTL 5 0.21 exercise endurance trait (VT:0002332) maximum distance run on treadmill (CMO:0001406) 3 73376539 118376539 Rat 8694437 Bw167 Body weight QTL 167 22.46 0.001 retroperitoneal fat pad mass (VT:0010430) retroperitoneal fat pad weight to body weight ratio (CMO:0000635) 3 91797474 136797474 Rat 2302273 Gluco35 Glucose level QTL 35 5.3 0.001 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 3 80800231 114297550 Rat 8662816 Vetf4 Vascular elastic tissue fragility QTL 4 4 renal artery integrity trait (VT:0010642) number of ruptures of the internal elastic lamina of the renal arteries (CMO:0002563) 3 59242096 157323038 Rat 1559282 Emca5 Estrogen-induced mammary cancer QTL 5 3.9 mammary gland integrity trait (VT:0010552) percentage of study population developing mammary tumors during a period of time (CMO:0000948) 3 43827364 169034231 Rat 1581503 Cm58 Cardiac mass QTL 58 2.7 0.05 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 3 43827364 121056321 Rat 2292613 Ept16 Estrogen-induced pituitary tumorigenesis QTL 16 8.3 pituitary gland mass (VT:0010496) pituitary gland wet weight (CMO:0000853) 3 47233430 110362260 Rat 1354611 Despr2 Despair related QTL 2 3.03 0.0028 locomotor behavior trait (VT:0001392) amount of time spent in voluntary immobility (CMO:0001043) 3 97084464 142084464 Rat 631649 Bp123 Blood pressure QTL 123 3.2 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 3 89772419 134772419 Rat 631841 Niddm39 Non-insulin dependent diabetes mellitus QTL 39 3.36 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 3 94856903 159898684 Rat 12879848 Bw181 Body weght QTL 181 0.015 body mass (VT:0001259) body weight (CMO:0000012) 3 70348525 121056321 Rat 2301971 Cm71 Cardiac mass QTL 71 4.63 heart left ventricle mass (VT:0007031) heart left ventricle weight (CMO:0000776) 3 41874578 155617519 Rat 2312659 Slep7 Serum leptin concentration QTL 7 0.001 blood leptin amount (VT:0005667) serum leptin level (CMO:0000780) 3 98535255 168026850 Rat 1358885 Bp251 Blood pressure QTL 251 3.8 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 3 14489145 121056321 Rat 2301970 Bw81 Body weight QTL 81 5.19 body mass (VT:0001259) body weight (CMO:0000012) 3 41874578 155617519 Rat 1581546 Pur13 Proteinuria QTL 13 2.93 0.0335 urine total protein amount (VT:0000032) urine protein excretion rate (CMO:0000759) 3 78196190 146592722 Rat 631665 Bw8 Body weight QTL 8 5.5 body mass (VT:0001259) body weight (CMO:0000012) 3 50437042 119183768 Rat 1358888 Bp264 Blood pressure QTL 264 4.43 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 3 14489145 121056321 Rat 2293087 Iddm27 Insulin dependent diabetes mellitus QTL 27 2.68 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 3 97551417 147415807 Rat 2312670 Bw94 Body weight QTL 94 0.01 inguinal fat pad mass (VT:0010424) inguinal fat pad weight to body weight ratio (CMO:0001253) 3 98535255 168026850 Rat 1358186 Ept2 Estrogen-induced pituitary tumorigenesis QTL 2 8.3 pituitary gland mass (VT:0010496) pituitary gland wet weight (CMO:0000853) 3 47233430 110362260 Rat 724532 Cm17 Cardiac mass QTL 17 2 heart mass (VT:0007028) calculated heart weight (CMO:0000073) 3 95735366 140735366 Rat
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
8
45
113
83
82
51
25
51
6
201
90
93
43
59
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000010959 ⟹ ENSRNOP00000010959
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 3 107,250,075 - 107,264,689 (-) Ensembl Rnor_6.0 Ensembl 3 112,072,330 - 112,084,144 (-) Ensembl
RefSeq Acc Id:
XM_063284968 ⟹ XP_063141038
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 3 127,702,603 - 127,720,429 (-) NCBI
RefSeq Acc Id:
XM_063284969 ⟹ XP_063141039
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 3 127,702,603 - 127,720,429 (-) NCBI
Ensembl Acc Id:
ENSRNOP00000010959 ⟸ ENSRNOT00000010959
RefSeq Acc Id:
XP_063141039 ⟸ XM_063284969
- Peptide Label:
isoform X2
RefSeq Acc Id:
XP_063141038 ⟸ XM_063284968
- Peptide Label:
isoform X1
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2008-03-06
Pla2g4f
phospholipase A2, group IVF
LOC691907
similar to cytosolic phospholipase A2 zeta
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2008-01-09
LOC691907
similar to cytosolic phospholipase A2 zeta
LOC688015
similar to cytosolic phospholipase A2 zeta
Data merged from RGD:1593647
1643240
APPROVED
2006-11-20
LOC691907
similar to cytosolic phospholipase A2 zeta
Symbol and Name status set to provisional
70820
PROVISIONAL
2006-11-20
LOC688015
similar to cytosolic phospholipase A2 zeta
Symbol and Name status set to provisional
70820
PROVISIONAL